Following the first confirmed case of HMPV in Greece, Professor Stelios Loukidis from the University of Athens discussed symptoms and protective measures against this upper respiratory virus. Identified since 2001, HMPV poses greater risks to children under five, the elderly, and individuals with weakened immune systems. The absence of specific treatments or vaccines necessitates traditional precautions like wearing masks and hand hygiene. Loukidis expressed no current concern about mutations from China affecting Greece, assuring that severe outbreaks are not anticipated at this time.